Drug Prescription and Administration Record

Similar documents
[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

MORPHINE ADMINISTRATION

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Palliative Care Impact Survey

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

Appendix: Sample prescription form. The following sample prescription form gives examples of sections found in most hospital prescription forms.

Care in the Last Days of Life

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration

Algorithms for Symptom Management. In End of Life Care

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment.

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Palliative care for heart failure patients. Susan Addie

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

End of life prescribing guidance

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

Conservative Management of Uraemia

MOD 4: Medication Administration

survey Parenteral anti-epileptics What is your experience? May July 2015

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

Chapter 2 is a general introduction to the drug administration

Drug CHAPTER 2. Pharmacologic Principles. NDEG 26A Eliza Rivera-Mitu, RN, MSN. Pharmacology. Drug Names. Pharmacologic Principles. Drug Names (cont'd)

MEDICATION OR OTHER SUBSTANCE

SYRINGE DRIVER MEDICATIONS

MEDICATION OR OTHER SUBSTANCE

Symptom Management Guidelines for End of Life Care

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

1. Intrathecal must never be abbreviated to IT on a prescription form True / False

Intravenous Immunoglobulin (IVIg) prescribing guidance

BREATHLESSNESS MANAGEMENT

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

HOW TO MANAGE AND ADMINISTER THE TRIAL TREATMENT

Trust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults

Ketorolac injection. Supportive care

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Acute Stroke with Alteplase Administration Order Set

IV Referral Standards for OPAT Services

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Chapter : Sources and Bodily Effect of Drugs

Medication Safety Presentation

Introduction to Pharmacokinetics

Medication Administration and Documentation. A NC Approved CE Class offered by

This document expires on Patient Group Direction No. VI 11

Protocol for administration of when required Medicines in Care Homes

Part 2: Pain and Symptom Management Nausea and Vomiting

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart

Attach patient label here. Physician Orders ADULT: Palliative Care Plan

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

What s New 2003? What new treatments? What have you discontinued? More information please!

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE

Pathology Service User Guide Haematology

Chapter 7. Principles of Pharmacology

NUH Medicines Policy: Code of Practice

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45

Palliative care for patients with brain cancer

Results of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital

British Columbia Medical Assistance in Dying Prescription

WITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS

Pharmacology. Pharmacology. Pharmacology. Safety the ultimate goal. Patient advocate. Responsible = responsive

Prescribing Examples: Basics

Part 1 Principles and Routes of Medication Administration

Essential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community

Physician Orders Pediatric: LEB ED Asthma Plan

Clinical Practice Guidelines Edition (Updated February 2018)

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Unit 204 Assist with the assembly of prescribed items

Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015)

Supportive Care. End of Life Phase

Sedation in children and young people. Appendix J. Sedation for diagnostic and therapeutic procedures in children and young people

Syringe driver in Palliative Care

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

Chapter 7. National EMS Education Standard Competencies (1 of 5) National EMS Education Standard Competencies (2 of 5) Principles of Pharmacology

patient group direction

Renal function: Known CKD AKI

Renal Palliative Care Last Days of Life

Suboptimal hydration harms patients.

Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University

** Medication exercises ** NICU Phase II

Transcription:

Chart No. this admission Drug Prescription and Administration Record Patient s Name: of Admission: Chart Start : Chart Finish : NHS No: Consultant Code: Ward: ALERT: of Birth: ADDITIONAL CAUTIONS FOR PRESCRIBING (e.g. renal failure, gastric ulceration etc) Tick if on CHEMOTHERAPY OTHER CHARTS in use Tick Box: Syringe driver Opioid patch Other Other DRUG SENSITIVITIES & REACTIONS ature: : ONCE ONLY / NURSE LED PRESCRIPTIONS See Approved Homely Remedies list Medicine Dose Route Instructions Start time Doctor s signature Time given Nurse s signature REMOTE PRESCRIPTIONS File Emergency Telephone Prescription of Drugs form in notes and document any doses given here Medicine Dose Route Instructions Time given Specify text/ email etc Nurse s signature Dr. signature (next working day) CODE FOR USE ON REGULAR AND PRN CHART R = drug refused by patient N = drug not in stock U = patient too unwell W = drug withheld O = patient out P = patient self-administration

INTRAVENOUS THERAPY AND SUBCUTANEOUS INFUSION FOR INFUSION FLUIDS, BLOOD, PLASMA AND DRUGS BY ONE CONTINUOUS INFUSION No additions to be made to blood products or sodium bicarbonate. For information on additive compatibilities contact acy Medicines Information. Infusion Fluid Additions to Infusion Time to Run or ml/hr Prescriber s signature Batch No. Pump Asset No. Time start Nurses signiture x2 Time end Amount infused Type/Strength Volume Route / Site Drug Dose Print name

DRUG SENSITIVITIES: DIAGNOSIS: Route Key IM = Intramuscular SC = Subcutaneous TOP = Topical NEB = Nebulised INH = Inhalation IV = Intravenous PR = Per Rectum PO = Oral / Enteral SL = Sublingual PV = Per Vaginam PEG = Percutaneous endoscopic gastrostomy BUC = Buccal TD = Transdermal NAS = Nasal REGULAR PRESCRIPTIONS MONTH DATE Drug Dose Route Frequency Start Special Instruction / Indication 0800 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800

REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start

REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start

REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start

REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start

PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig MIDAZOLAM Dose / Range Route Max Freq Start IM only to be used in the event of a CRISIS (e.g. massive haemorrhage, airway obstruction) Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start

PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start

PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start

PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start

SUBCUTANEOUS SYRINGE DRIVER PRESCRIPTION CHART Prescription to be monitored using Checks In Use form 1 Dose 2 Dose (Dr) Started (Dr) Started Stopped Stopped 3 Dose 4 Dose (Dr) Started (Dr) Started Stopped Stopped 5 Dose 6 Dose (Dr) Started (Dr) Started Stopped Stopped 7 Dose 8 Dose (Dr) Started (Dr) Started Stopped Stopped